Exhibit 31


CERTIFICATION


     Pursuant to the requirements of Rule 13a-14 of the Securities Exchange Act
of 1934, as amended, James R. Musick provides the following certification.

     I, James R. Musick, President, Chairman of the Board and Chief Executive
Officer of Vitro Diagnostics, Inc. ("Company"), certify that:

     1. I have reviewed this annual report on Form 10-KSB of the Company;

     2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;

     3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
Company as of, and for, the periods presented in this annual report;

     4. I am responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the
Company and have:

          a. Designed such disclosure controls and procedures to ensure that
     material information relating to the Company is made known to me by others,
     particularly during the period in which this annual report is being
     prepared;

          b. Evaluated the effectiveness of the Company's disclosure controls
     and procedures as of a date within 90 days prior to the filing date of this
     annual report (the "Evaluation Date"); and

          c. Presented in this quarterly report our conclusions about the
     effectiveness of the disclosure controls and procedures based on our
     evaluation as of the Evaluation Date;

     5. I have disclosed, based on my most recent evaluation, to the Company's
auditors and the audit committee of our board of directors (or persons
performing the equivalent functions):

          a. All significant deficiencies in the design or operation of internal
     controls which could adversely affect the Company's ability to record,
     process, summarize and report financial data and have identified for the
     Company's auditors any material weaknesses in internal controls, and

          b. Any fraud, whether or not material, that involves management or
     other employees who have a significant role in the Company's internal
     controls; and

     6. I have indicated in this annual report whether or not there were
significant changes in internal controls or in other factors that could
significantly affect internal controls subsequent to the date of my most recent
evaluation, including any corrective actions with regard to significant
deficiencies and material weaknesses.



Date: February 4, 2005                      /s/  James R. Musick
      ----------------                      ----------------------------------
                                                 James R. Musick, President,
                                                 Chief Executive Officer,
                                                 Principal Financial and
                                                 Accounting Officer